Pfizer Plans to Increase U.S. Drug Prices in January

NEW YORK (Reuters)—Pfizer Inc. said on Friday that it plans to hike U.S. prices on 41 of its medicines in January, after walking back its previous price increases this summer under pressure from President Donald Trump. The company said in a statement that the increases would be on around 10% of its drugs. Pfizer said... [Read More]
Source: The Rheumatologist - Category: Rheumatology Authors: Tags: Drug Updates Pharma Co. News drug costs drug prices drug pricing Pfizer Inc. Source Type: research